State Street’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Sell
2,218,533
-8,318
-0.4% -$6.08K ﹤0.01% 3370
2025
Q1
$1.8M Buy
2,226,851
+49,820
+2% +$40.2K ﹤0.01% 3284
2024
Q4
$3M Buy
2,177,031
+150,699
+7% +$208K ﹤0.01% 3178
2024
Q3
$2.11M Buy
2,026,332
+13,579
+0.7% +$14.1K ﹤0.01% 3313
2024
Q2
$3.48M Buy
2,012,753
+17,015
+0.9% +$29.4K ﹤0.01% 3083
2024
Q1
$4.77M Sell
1,995,738
-68,588
-3% -$164K ﹤0.01% 2944
2023
Q4
$6.87M Sell
2,064,326
-6,726,601
-77% -$22.4M ﹤0.01% 2782
2023
Q3
$32.9M Buy
8,790,927
+6,238,667
+244% +$23.3M ﹤0.01% 1866
2023
Q2
$10.9M Sell
2,552,260
-3,545,323
-58% -$15.1M ﹤0.01% 2609
2023
Q1
$41.7M Sell
6,097,583
-688,399
-10% -$4.71M ﹤0.01% 1777
2022
Q4
$53.7M Buy
6,785,982
+1,680,211
+33% +$13.3M ﹤0.01% 1585
2022
Q3
$49.1M Sell
5,105,771
-1,277,332
-20% -$12.3M ﹤0.01% 1608
2022
Q2
$46.2M Buy
6,383,103
+1,218,951
+24% +$8.83M ﹤0.01% 1700
2022
Q1
$66.7M Buy
5,164,152
+1,343,032
+35% +$17.3M ﹤0.01% 1582
2021
Q4
$61M Sell
3,821,120
-212,586
-5% -$3.39M ﹤0.01% 1675
2021
Q3
$64.8M Sell
4,033,706
-1,040,435
-21% -$16.7M ﹤0.01% 1612
2021
Q2
$70.2M Buy
5,074,141
+241,760
+5% +$3.34M ﹤0.01% 1592
2021
Q1
$70.6M Buy
4,832,381
+213,331
+5% +$3.12M ﹤0.01% 1486
2020
Q4
$80.3M Buy
4,619,050
+324,644
+8% +$5.64M ﹤0.01% 1314
2020
Q3
$78.8M Sell
4,294,406
-881,740
-17% -$16.2M 0.01% 1131
2020
Q2
$92.4M Buy
5,176,146
+1,673,152
+48% +$29.9M 0.01% 1015
2020
Q1
$56.8M Buy
3,502,994
+16,517
+0.5% +$268K 0.01% 1173
2019
Q4
$62.8M Buy
3,486,477
+702,638
+25% +$12.7M ﹤0.01% 1359
2019
Q3
$56.4M Buy
2,783,839
+342,885
+14% +$6.95M ﹤0.01% 1366
2019
Q2
$53.9M Buy
2,440,954
+214,286
+10% +$4.74M ﹤0.01% 1442
2019
Q1
$30.4M Sell
2,226,668
-417,455
-16% -$5.69M ﹤0.01% 1771
2018
Q4
$23.9M Buy
2,644,123
+464,506
+21% +$4.2M ﹤0.01% 1859
2018
Q3
$36M Buy
2,179,617
+73,013
+3% +$1.2M ﹤0.01% 1781
2018
Q2
$29.5M Buy
2,106,604
+187,305
+10% +$2.62M ﹤0.01% 1862
2018
Q1
$21.2M Sell
1,919,299
-185,211
-9% -$2.05M ﹤0.01% 2012
2017
Q4
$18.5M Buy
2,104,510
+228,407
+12% +$2.01M ﹤0.01% 2098
2017
Q3
$25M Buy
1,876,103
+459,531
+32% +$6.13M ﹤0.01% 1864
2017
Q2
$20.3M Buy
1,416,572
+298,986
+27% +$4.29M ﹤0.01% 1968
2017
Q1
$23.6M Buy
1,117,586
+167,111
+18% +$3.53M ﹤0.01% 1812
2016
Q4
$26.8M Buy
950,475
+148,768
+19% +$4.19M ﹤0.01% 1682
2016
Q3
$21.5M Buy
801,707
+342,829
+75% +$9.18M ﹤0.01% 1728
2016
Q2
$7.75M Buy
458,878
+85,658
+23% +$1.45M ﹤0.01% 2359
2016
Q1
$7.93M Buy
373,220
+6,554
+2% +$139K ﹤0.01% 2307
2015
Q4
$8.42M Buy
366,666
+9,899
+3% +$227K ﹤0.01% 2286
2015
Q3
$7.15M Buy
356,767
+92,885
+35% +$1.86M ﹤0.01% 2352
2015
Q2
$7.63M Buy
263,882
+183,075
+227% +$5.29M ﹤0.01% 2413
2015
Q1
$2.47M Buy
80,807
+47,929
+146% +$1.46M ﹤0.01% 2944
2014
Q4
$537K Buy
+32,878
New +$537K ﹤0.01% 3378